Ellie McGuire

Ms. Ellie McGuire is a partner in the Polaris Partners Boston office and also manages the Polaris Innovation Fund.

McGuire currently serves on the Boards of Muna Therapeutics, Montis Biosciences, Candesant Biomedical, and Volastra Therapeutics, the latter of which she was the founding president. She is an expert in residence for the Harvard Office of Technology Development.

Prior to co-founding the Polaris Innovation Fund, McGuire was the head of business development at Lyndra.

She previously held leadership and consulting positions in business development, operations, and strategy in multiple life science companies including Arsia Therapeutics, Lyndra, and XTuit Pharmaceuticals.